XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity
6 Months Ended
Jul. 01, 2022
Stockholders Equity Note [Abstract]  
Stockholders' Equity

Note 10 — Stockholders’ Equity

Stock-Based Compensation

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 1, 2022

 

 

July 2, 2021

 

 

July 1, 2022

 

 

July 2, 2021

 

Employee stock options

 

$

2,457

 

 

$

2,784

 

 

$

4,784

 

 

$

5,256

 

Restricted stock

 

 

442

 

 

 

232

 

 

 

551

 

 

 

398

 

Restricted stock units

 

 

1,231

 

 

 

811

 

 

 

1,993

 

 

 

1,348

 

Performance stock units

 

 

1,310

 

 

 

108

 

 

 

1,692

 

 

 

201

 

Nonemployee stock options

 

 

314

 

 

 

57

 

 

 

628

 

 

 

119

 

Total stock-based compensation expense

 

$

5,754

 

 

$

3,992

 

 

$

9,648

 

 

$

7,322

 

 

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 1, 2022

 

 

July 2, 2021

 

 

July 1, 2022

 

 

July 2, 2021

 

Cost of sales

 

$

106

 

 

$

54

 

 

$

176

 

 

$

89

 

General and administrative

 

 

2,806

 

 

 

1,815

 

 

 

4,587

 

 

 

3,254

 

Selling and marketing

 

 

1,324

 

 

 

953

 

 

 

2,213

 

 

 

1,786

 

Research and development

 

 

1,518

 

 

 

1,170

 

 

 

2,672

 

 

 

2,193

 

Total stock-based compensation expense, net

 

 

5,754

 

 

 

3,992

 

 

 

9,648

 

 

 

7,322

 

Amounts capitalized as part of inventory

 

 

652

 

 

 

390

 

 

 

1,018

 

 

 

699

 

Total stock-based compensation expense, gross

 

$

6,406

 

 

$

4,382

 

 

$

10,666

 

 

$

8,021

 

 

 

Note 10 — Stockholders’ Equity (Continued)

Incentive Plan

The Amended and Restated Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, restricted stock units (“RSUs”) and performance stock units (“PSUs”). Options under the Plan are granted at fair market value on the date of grant, become exercisable generally over a three-year period, or as determined by the Board of Directors, and expire over periods not exceeding 10 years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control and pre-established financial metrics are met (as defined in the Plan). Grants of restricted stock outstanding under the Plan generally vest over periods of one to three years. Grants of RSUs and PSUs outstanding under the Plan generally vest based on service, performance, or a combination of both.  As of July 1, 2022, there were 2,156,185 shares available for grant under the Plan.

Assumptions

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table.  Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations and represents the period of time that options granted are expected to be outstanding.  The Company has calculated a 5% estimated forfeiture rate based on historical forfeiture experience.  The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.  

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 1, 2022

 

 

July 2, 2021

 

 

July 1, 2022

 

 

July 2, 2021

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

54

%

 

 

53

%

 

 

54

%

 

 

53

%

Risk-free interest rate

 

 

3.27

%

 

 

0.83

%

 

 

1.83

%

 

 

0.84

%

Expected term (in years)

 

 

5.10

 

 

 

5.38

 

 

 

5.10

 

 

 

5.38

 

 

Stock Options

A summary of stock option activity under the Plan for six months ended July 1, 2022 is presented below:

 

 

 

Stock

Options

(in 000’s)

 

 

Minimum

Exercise

Price

 

 

Maximum

Exercise

Price

 

Outstanding at December 31, 2021

 

 

2,435

 

 

 

 

 

 

 

 

 

Granted

 

 

421

 

 

 

 

 

 

 

 

 

Exercised

 

 

(251

)

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(16

)

 

 

 

 

 

 

 

 

Outstanding at July 1, 2022

 

 

2,589

 

 

$

5.34

 

 

$

154.96

 

Exercisable at July 1, 2022

 

 

1,873

 

 

 

 

 

 

 

 

 

 

Restricted Stock, Restricted Stock Units and Performance Stock Units

A summary of restricted stock, RSUs and PSUs activity under the Plan for the six months ended July 1, 2022 is presented below (shares in thousands):

 

 

 

Restricted

Stock

 

 

RSUs

 

 

PSUs

 

Unvested at December 31, 2021

 

 

3

 

 

 

131

 

 

 

10

 

Granted

 

 

6

 

 

 

113

 

 

 

113

 

Vested

 

 

(5

)

 

 

(45

)

 

 

(5

)

Unvested at July 1, 2022

 

 

4

 

 

 

199

 

 

 

118